Table I.
AML | ALL | CML | CLL | MDS | Total | |
---|---|---|---|---|---|---|
Total, n | 40 | 8 | 3 | 2 | 3 | 56 |
Male, n | 22 | 8 | 3 | 1 | 3 | 37 |
Female, n | 18 | 0 | 0 | 1 | 0 | 19 |
Age, years, mean ± SD (range) | 47.9 ± 15.6 (15–72) | 30.9 ± 18.0 (1–48) | 60 ± 14.4 (44–72) | 66.5 ± 10.6 (59–74) | 30.3 ± 25.0 (6–56) | 45.8 ± 17.9 (1–74) |
Patients less than 20 years old, n (%) | 3 (8) | 3 (38) | 0 | 0 | 1 (33) | 7 (13) |
AML: acute myelogenous leukaemia; ALL: acute lymphoblastic leukaemia; CML: chronic myeloid leukaemia; CLL: chronic lymphocytic leukaemia; MDS: myelodysplastic syndrome; SD: standard deviation.